Zavicefta Європейський Союз - румунська - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacteriene pentru uz sistemic, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. trebuie luate în considerare ghidurile oficiale referitoare la utilizarea adecvată a medicamentelor antibacteriene.

SUNITINIB SANDOZ 12,5 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sunitinib sandoz 12,5 mg

remedica ltd - cipru - sunitinibum - caps. - 12,5mg - alte antineoplazice inhibitori de protein-kinaza

SUNITINIB SANDOZ 25 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sunitinib sandoz 25 mg

remedica ltd - cipru - sunitinibum - caps. - 25mg - alte antineoplazice inhibitori de protein-kinaza

SUNITINIB SANDOZ 50 mg Румунія - румунська - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sunitinib sandoz 50 mg

remedica ltd - cipru - sunitinibum - caps. - 50mg - alte antineoplazice inhibitori de protein-kinaza